CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 15,333	$ 12,970	$ 30,613	$ 21,911
General and administrative	6,459	5,410	13,979	10,199
Total operating expenses	21,792	18,380	44,592	32,110
Loss from operations	(21,792)	(18,380)	(44,592)	(32,110)
Other income:
Interest income	133	10	196	17
Total other income	133	10	196	17
Net loss	(21,659)	(18,370)	(44,396)	(32,093)
Cumulative dividends on redeemable convertible preferred stock				(1,228)
Net loss attributable to common stockholders	$ (21,659)	$ (18,370)	$ (44,396)	$ (33,321)
Net loss per share attributable to common stockholders, basic	$ (0.58)	$ (0.50)	$ (1.19)	$ (1.13)
Net loss per share attributable to common stockholders, diluted	$ (0.58)	$ (0.50)	$ (1.19)	$ (1.13)
Weighted Average Number of Shares Outstanding, Basic	37,437,063	36,843,087	37,365,647	29,593,814
Weighted Average Number of Shares Outstanding, Diluted	37,437,063	36,843,087	37,365,647	29,593,814
Other comprehensive loss:
Unrealized loss on available for sale investments	$ (254)		$ (1,326)
Total other comprehensive loss	(254)		(1,326)
Comprehensive loss attributable to common stockholders	$ (21,913)	$ (18,370)	$ (45,722)	$ (33,321)